ArticleHaematologica2023

Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia.

Ibrahim Aldoss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.